Drug Details
Ertapenem
"(4R,5S,6S)-3-{[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid"
powered by Marvin.Double Click on the chemical would show a detailed plugin for structural view
TOP TCM candidates
Score | ID | English Name | Chinese Name |
---|
Basic Database Information
Drug Generic Name:Ertapenem
Database ID : 296
Drugbank ID : DB00303
WikiPedia Link: http://en.wikipedia.org/wiki/Ertapenem
Basic Chemical Information
Drug Generic Name:Ertapenem
Chemical Formula:C22H25N3O7S
Molecular Weight:475.515
Synonyms: MK-0826
Description: Ertapenem is a carbapenem antibiotic marketed by Merck as Invanz®. It is structurally very similar to meropenem in that it possess a 1-beta-methyl group. [Wikipedia]
Toxicity: Not Available
Indication: "For the treatment the following moderate to severe infections caused by susceptible isolates of the designated microorganisms: (1) complicated intra-abdominal infections due to <i>Escherichia coli</i>, <i>Clostridium clostridioforme</i>, <i>Eubacterium lentum</i>, <i>Peptostreptococcus</i> species, <i>Bacteroides fragilis</i>, <i>Bacteroides distasonis</i>, <i>Bacteroides ovatus</i>, <i>Bacteroides thetaiotaomicron</i>, or <i>Bacteroides uniformis</i>, (2) complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis due to <i>Staphylococcus aureus</i> (methicillin susceptible isolates only), <i>Streptococcus agalactiae</i>, <i>Streptococcus pyogenes</i>, <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, <i>Proteus mirabilis</i>, <i>Bacteroides fragilis</i>, <i>Peptostreptococcus</i> species, <i>Porphyromonas asaccharolytica</i>, or <i>Prevotella bivia</i>, (3) community acquired pneumonia due to <i>Streptococcus pneumoniae</i> (penicillin susceptible isolates only) including cases with concurrent bacteremia, <i>Haemophilus influenzae</i> (beta-lactamase negative isolates only), or <i>Moraxella catarrhalis</i>, (4) complicated urinary tract infections including pyelonephritis due to <i>Escherichia coli</i>, including cases with concurrent bacteremia, or <i>Klebsiella pneumoniae</i>, (5) acute pelvic infections including postpartum endomyometritis, septic abortion and post surgical gynecologic infections due to <i>Streptococcus agalactiae</i>, <i>Escherichia coli</i>, <i>Bacteroides fragilis</i>, <i>Porphyromonas asaccharolytica</i>, <i>Peptostreptococcus</i> species, or <i>Prevotella bivia</i>."
Absorption: The mean bioavailability is approximately 90%.
Biotransformation: "The major metabolite is the inactive ring-opened derivative formed by hydrolysis of the β-lactam ring. Ertapenem did not inhibit metabolism mediated by cytochrome P450 (CYP) isoforms 1A2, 2C9, 2C19, 2D6, 2E1, or 3A4 when evaluated by in vitro studies in human liver microsomes."
Experimental LogP Hydrophobicity: 0.3
Experimental Water Solubility: Soluble as sodium salt
Half life: The mean plasma half-life is approximately 4 hours.
Brand Mixtures: Not Available
pKa Isoelectric Point: Not Available
Pharmacology: Ertapenem has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria.
Related Database Information
AHFS Codes:08:12.07.08
ATC Codes:J01DH03
CAS registry Number:153832-46-3
ChEBI ID:15449
DPD Drug ID Number:2247437
GenBank ID:Not Available
HET ID: Not Available
SwissProt ID: Not Available
SwissProt Name: Not Available
PDB experimental ID: Not Available
PDB Homology ID: Not Available
PharmGKB ID: PA10073
Corresponding Targets
ID | Name | General Function |
---|---|---|
115 | Penicillin-binding protein 2 | Cell wall/membrane/envelope biogenesis |
1 | Peptidoglycan synthetase ftsI | Cell wall/membrane/envelope biogenesis |
4155 | Peptidoglycan synthetase ftsI | Involved in penicillin binding |
543 | Penicillin-binding protein 1B | Cell wall/membrane/envelope biogenesis |
6069 | Penicillin-binding protein 2 | Cell wall/membrane/envelope biogenesis |
6184 | D-alanyl-D-alanine carboxypeptidase dacC | Cell wall/membrane/envelope biogenesis |
645 | Penicillin-binding protein 1A | Cell wall/membrane/envelope biogenesis |
819 | Penicillin-binding protein 4 | Cell wall/membrane/envelope biogenesis |